This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To assess the neuropsychological outcome 12 months after bilateral deep brain stimulation (DBS) of the globus pallidus pars interna (GPi) or subthalamic nucleus (STN) for advanced Parkinson disease.
Methods: We randomly assigned patients to receive either GPi DBS or STN DBS. Standardized neuropsychological tests were performed at baseline and after 12 months. Patients and study assessors were masked to treatment allocation.
Results: Univariate analysis of change scores indicated group differences on Stroop word reading and Stroop color naming (confidence interval [CI] 1.9–10.0 and 2.1–8.8), on Trail Making Test B (CI 0.5–10.3), and on Wechsler Adult Intelligence Scale similarities (CI −0.01 to 1.5), with STN DBS showing greater negative change than GPi DBS. No differences were found between GPi DBS and STN DBS on the other neuropsychological tests. Older age and better semantic fluency at baseline predicted cognitive decline after DBS.
Conclusions: We found no clinically significant differences in neuropsychological outcome between GPi DBS and STN DBS. No satisfactory explanation is available for the predictive value of baseline semantic fluency for cognitive decline.
Classification of evidence: This study provides Class I evidence that there is no large difference in neuropsychological outcome between GPi DBS and STN DBS after 12 months. The study lacks the precision to exclude a moderate difference in outcomes.
GLOSSARY
- CI=
- confidence interval;
- DBS=
- deep brain stimulation;
- GPi=
- globus pallidus pars interna;
- LED=
- levodopa equivalent dose;
- MDRS=
- Mattis Dementia Rating Scale;
- NSTAPS=
- Netherlands Subthalamic and Pallidal Stimulation;
- OR=
- odds ratio;
- PD=
- Parkinson disease;
- PDQL=
- Parkinson's Disease Quality of Life Questionnaire;
- QOL=
- quality of life;
- RAVLT=
- Rey Auditory Verbal Learning Test;
- RBMT=
- Rivermead Behavioral Memory Test;
- RCI=
- reliable change index;
- STN=
- subthalamic nucleus;
- TMTA=
- Trail Making Test part A;
- TMTB=
- Trail Making Test part B;
- UPDRS=
- Unified Parkinson's Disease Rating Scale;
- WAIS-III=
- Wechsler Adult Intelligence Scale III
Footnotes
↵* These authors contributed equally to this work.
Coinvestigators are listed on the Neurology® Web site at Neurology.org.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received August 4, 2014.
- Accepted in final form December 15, 2014.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
- Reply to letter on 'Neuropsychological outcome after deep brain stimulation for Parkinson disease'
- STN vs GPi DBS; the data are in.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.